Becton Dickinson Future Growth
Future criteria checks 2/6
Becton Dickinson is forecast to grow earnings and revenue by 17.4% and 5.3% per annum respectively. EPS is expected to grow by 18.1% per annum. Return on equity is forecast to be 15.4% in 3 years.
Key information
17.4%
Earnings growth rate
18.1%
EPS growth rate
| Medical Equipment earnings growth | 16.5% |
| Revenue growth rate | 5.3% |
| Future return on equity | 15.4% |
| Analyst coverage | Good |
| Last updated | 10 Apr 2024 |
Recent future growth updates
Recent updates
Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)
Mar 23
Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)
Feb 29Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings
Feb 08Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 03These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well
Feb 01Becton, Dickinson: 4 Reasons To Buy This Growth At A Reasonable Price Play
Jan 22Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 30Becton, Dickinson And Company: Strong Q4 But Clouded By 75bps Growth Headwind From China In FY24
Nov 13Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's
Nov 12Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price
Nov 06With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case
Oct 05Becton, Dickinson Stock Is A Hold, Here's Why
Oct 04Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers
Aug 30We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt
Aug 13Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Jul 28Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching
Jun 22Becton, Dickinson and Company: Still Not Very Healthy
Jun 20Becton, Dickinson: Business Should Beat H2 2023 Expectations
Jun 08These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well
Apr 22Is Now The Time To Put Becton Dickinson (NYSE:BDX) On Your Watchlist?
Mar 20Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Mar 05Becton, Dickinson HPV test Onclarity gets FDA nod for expanded use
Feb 21Becton, Dickinson wins FDA nod for flu, COVID, RSV combo test
Feb 08Becton, Dickinson Q1 2023 Earnings Preview
Feb 01Becton, Dickinson declares $0.91 dividend
Jan 24We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt
Jan 09CerTest/Becton, Dickinson's test for monkeypox gets FDA emergency use nod
Jan 09Becton, Dickinson: A Quality Defensive Pick For 2023
Dec 20Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Dec 01Becton Dickinson (NYSE:BDX) Is Increasing Its Dividend To $0.91
Nov 13Becton, Dickinson Q4 2022 Earnings Preview
Nov 09Becton, Dickinson, Biocorp team up for traceability of injectable drugs
Oct 18Becton, Dickinson: Buy In Now While You Can
Oct 12Does Becton Dickinson (NYSE:BDX) Have A Healthy Balance Sheet?
Oct 05BD, Certest Biotec launch monkeypox test
Sep 26Becton, Dickinson launches next-gen prefillable vaccine syringe BD Effivax
Sep 13Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2026 | 22,698 | 2,844 | 3,344 | 4,299 | 6 |
| 9/30/2025 | 21,502 | 2,627 | 2,973 | 3,900 | 13 |
| 9/30/2024 | 20,314 | 2,111 | 3,761 | 3,764 | 13 |
| 12/31/2023 | 19,492 | 1,265 | 2,649 | 3,431 | N/A |
| 9/30/2023 | 19,372 | 1,470 | 2,115 | 2,989 | N/A |
| 6/30/2023 | 19,046 | 1,582 | 1,878 | 2,773 | N/A |
| 3/31/2023 | 18,809 | 1,556 | 1,144 | 2,101 | N/A |
| 12/31/2022 | 18,738 | 1,486 | 1,361 | 2,359 | N/A |
| 9/30/2022 | 18,870 | 1,545 | 1,661 | 2,634 | N/A |
| 6/30/2022 | 18,958 | 1,412 | 1,465 | 2,575 | N/A |
| 3/31/2022 | 18,924 | 1,430 | 2,041 | 3,141 | N/A |
| 12/31/2021 | 18,534 | 1,079 | 2,620 | 3,751 | N/A |
| 9/30/2021 | 19,131 | 1,514 | 3,453 | 4,647 | N/A |
| 6/30/2021 | 19,066 | 1,486 | 4,222 | 5,177 | N/A |
| 3/31/2021 | 18,313 | 1,379 | 4,150 | 5,064 | N/A |
| 12/31/2020 | 18,207 | 1,507 | 3,476 | 4,359 | N/A |
| 9/30/2020 | 16,074 | 245 | 2,728 | 3,497 | N/A |
| 6/30/2020 | 16,917 | 786 | 2,474 | 3,429 | N/A |
| 3/31/2020 | 17,414 | 923 | 2,509 | 3,499 | N/A |
| 12/31/2019 | 17,355 | 760 | 2,835 | 3,798 | N/A |
| 9/30/2019 | 17,290 | 1,081 | 2,373 | 3,330 | N/A |
| 6/30/2019 | 17,108 | 784 | 2,359 | 3,265 | N/A |
| 3/31/2019 | 17,036 | 926 | 2,009 | 2,875 | N/A |
| 12/31/2018 | 17,063 | 894 | 1,906 | 2,790 | N/A |
| 9/30/2018 | 15,983 | 159 | 1,970 | 2,865 | N/A |
| 6/30/2018 | 14,747 | 621 | 1,837 | 2,685 | N/A |
| 3/31/2018 | 13,503 | -99 | 1,681 | 2,527 | N/A |
| 12/31/2017 | 12,251 | 294 | 1,762 | 2,555 | N/A |
| 9/30/2017 | 12,093 | 1,030 | N/A | 2,550 | N/A |
| 6/30/2017 | 12,158 | 759 | N/A | 2,129 | N/A |
| 3/31/2017 | 12,321 | 1,314 | N/A | 2,579 | N/A |
| 12/31/2016 | 12,419 | 1,309 | N/A | 2,411 | N/A |
| 9/30/2016 | 12,483 | 976 | N/A | 2,559 | N/A |
| 6/30/2016 | 12,312 | 1,139 | N/A | 2,532 | N/A |
| 3/31/2016 | 12,234 | 810 | N/A | 2,236 | N/A |
| 12/31/2015 | 11,217 | 688 | N/A | 1,907 | N/A |
| 9/30/2015 | 10,282 | 695 | N/A | 1,730 | N/A |
| 6/30/2015 | 9,410 | 815 | N/A | 1,591 | N/A |
| 3/31/2015 | 8,448 | 1,079 | N/A | 1,492 | N/A |
| 12/31/2014 | 8,468 | 1,150 | N/A | 1,677 | N/A |
| 9/30/2014 | 8,446 | 1,185 | N/A | 1,746 | N/A |
| 6/30/2014 | 8,345 | 974 | N/A | 1,876 | N/A |
| 3/31/2014 | 8,239 | 941 | N/A | 1,830 | N/A |
| 12/31/2013 | 8,169 | 930 | N/A | 1,626 | N/A |
| 9/30/2013 | 8,054 | 929 | N/A | 1,505 | N/A |
| 6/30/2013 | 7,920 | 1,114 | N/A | 1,405 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BDX's forecast earnings growth (17.4% per year) is above the savings rate (2.3%).
Earnings vs Market: BDX's earnings (17.4% per year) are forecast to grow faster than the US market (14.5% per year).
High Growth Earnings: BDX's earnings are forecast to grow, but not significantly.
Revenue vs Market: BDX's revenue (5.3% per year) is forecast to grow slower than the US market (8.1% per year).
High Growth Revenue: BDX's revenue (5.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BDX's Return on Equity is forecast to be low in 3 years time (15.4%).